FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1505768107> ?p ?o ?g. }

• W1505768107 endingPage "1186" @default.
• W1505768107 startingPage "1172" @default.
• W1505768107 abstract "Patients who have neuroendocrine tumors frequently present with liver metastases. A wide panel of treatment options exists for these patients. Liver resection with curative intent achieves the best long‐term results. Highly selected patients may be considered for liver transplantation. Substantial recurrence rates reported after surgical approaches call for neoadjuvant and adjuvant concepts. Liver‐directed, locally ablative procedures are recommended for patients with limited, nonresectable tumor burden. Angiographic liver‐directed techniques, such as transarterial embolization, transarterial chemoembolization, and selective internal radiotherapy, offer excellent palliation for patients with liver‐predominant disease. Peptide receptor radionuclide therapy is a promising palliative procedure for patients with hepatic and/or extrahepatic metastases. The efficacy of these treatment options needs to be evaluated in randomized trials. Somatostatin analogues have demonstrated effectiveness not only for symptomatic relief in patients with secreting tumors but also for the control of proliferation in small intestinal neuroendocrine tumors and most recently also in those originating from the pancreas. Chemotherapy is an option mainly for those with pancreatic neuroendocrine tumors and high‐grade tumors irrespective of the origin. Novel drugs targeting specific pathways within the tumor cell have produced improved progression‐free survival compared with placebo in patients with pancreatic neuroendocrine tumors. Despite such a diverse armamentarium, there is uncertainty with regard to the optimal treatment regimens. Newly introduced molecular‐based markers, along with the conduction of clinical trials comparing the efficacy of treatment modalities, offer a chance to move the treatment of neuroendocrine tumor disease toward personalized patient care. In this report, the authors review the approaches for treatment of neuroendocrine liver metastases, identify shortcomings, and anticipate future perspectives. Furthermore, clinical practice recommendations are provided for currently available treatment options. Although multiple modalities are available for the treatment of neuroendocrine liver metastases, optimal management is unclear. The current knowledge pertaining to these treatment options is analyzed. Cancer 2015;121:1172–1186. © 2014 American Cancer Society ." @default.
• W1505768107 created "2016-06-24" @default.
• W1505768107 creator A5002181117 @default.
• W1505768107 creator A5063926894 @default.
• W1505768107 date "2014-10-01" @default.
• W1505768107 modified "2023-10-14" @default.
• W1505768107 title "Therapeutic strategies for neuroendocrine liver metastases" @default.
• W1505768107 cites W1495055668 @default.
• W1505768107 cites W1532334298 @default.
• W1505768107 cites W1842586218 @default.
• W1505768107 cites W1898704081 @default.
• W1505768107 cites W1935825021 @default.
• W1505768107 cites W1963519902 @default.
• W1505768107 cites W1965535343 @default.
• W1505768107 cites W1970282846 @default.
• W1505768107 cites W1972649112 @default.
• W1505768107 cites W1973167936 @default.
• W1505768107 cites W1974264673 @default.
• W1505768107 cites W1975031233 @default.
• W1505768107 cites W1975544745 @default.
• W1505768107 cites W1982345319 @default.
• W1505768107 cites W1985844593 @default.
• W1505768107 cites W1988370994 @default.
• W1505768107 cites W1988570446 @default.
• W1505768107 cites W1988986189 @default.
• W1505768107 cites W1990509102 @default.
• W1505768107 cites W1994858697 @default.
• W1505768107 cites W1998610181 @default.
• W1505768107 cites W2000502435 @default.
• W1505768107 cites W2000600513 @default.
• W1505768107 cites W2001025514 @default.
• W1505768107 cites W2003291711 @default.
• W1505768107 cites W2005250386 @default.
• W1505768107 cites W2005592453 @default.
• W1505768107 cites W2005735759 @default.
• W1505768107 cites W2006747460 @default.
• W1505768107 cites W2006821285 @default.
• W1505768107 cites W2007525028 @default.
• W1505768107 cites W2008407321 @default.
• W1505768107 cites W2009629472 @default.
• W1505768107 cites W2010390727 @default.
• W1505768107 cites W2011124928 @default.
• W1505768107 cites W2013603665 @default.
• W1505768107 cites W2014034361 @default.
• W1505768107 cites W2014356332 @default.
• W1505768107 cites W2014505054 @default.
• W1505768107 cites W2015149820 @default.
• W1505768107 cites W2017225490 @default.
• W1505768107 cites W2018338654 @default.
• W1505768107 cites W2020357816 @default.
• W1505768107 cites W2023215996 @default.
• W1505768107 cites W2023481027 @default.
• W1505768107 cites W2024572430 @default.
• W1505768107 cites W2027376315 @default.
• W1505768107 cites W2027676394 @default.
• W1505768107 cites W2028133886 @default.
• W1505768107 cites W2028812797 @default.
• W1505768107 cites W2030532139 @default.
• W1505768107 cites W2031507753 @default.
• W1505768107 cites W2032215458 @default.
• W1505768107 cites W2033315405 @default.
• W1505768107 cites W2035214608 @default.
• W1505768107 cites W2036666478 @default.
• W1505768107 cites W2038388639 @default.
• W1505768107 cites W2041976618 @default.
• W1505768107 cites W2042124865 @default.
• W1505768107 cites W2045541968 @default.
• W1505768107 cites W2046559051 @default.
• W1505768107 cites W2047663691 @default.
• W1505768107 cites W2047997288 @default.
• W1505768107 cites W2050884534 @default.
• W1505768107 cites W2052269845 @default.
• W1505768107 cites W2054627587 @default.
• W1505768107 cites W2058244800 @default.
• W1505768107 cites W2058491683 @default.
• W1505768107 cites W2061150173 @default.
• W1505768107 cites W2061324512 @default.
• W1505768107 cites W2061345028 @default.
• W1505768107 cites W2062785452 @default.
• W1505768107 cites W2064745852 @default.
• W1505768107 cites W2065170253 @default.
• W1505768107 cites W2066932931 @default.
• W1505768107 cites W2069386429 @default.
• W1505768107 cites W2069860661 @default.
• W1505768107 cites W2069999129 @default.
• W1505768107 cites W2070625017 @default.
• W1505768107 cites W2071618269 @default.
• W1505768107 cites W2073693064 @default.
• W1505768107 cites W2074002594 @default.
• W1505768107 cites W2074821984 @default.
• W1505768107 cites W2078325088 @default.
• W1505768107 cites W207864156 @default.
• W1505768107 cites W2079144528 @default.
• W1505768107 cites W2080519663 @default.
• W1505768107 cites W2081019043 @default.
• W1505768107 cites W2082891425 @default.
• W1505768107 cites W2085027830 @default.
• W1505768107 cites W2085929116 @default.

• next